BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 16392080)

  • 1. Low risk of hemolytic uremic syndrome after early effective antimicrobial therapy for Shigella dysenteriae type 1 infection in Bangladesh.
    Bennish ML; Khan WA; Begum M; Bridges EA; Ahmed S; Saha D; Salam MA; Acheson D; Ryan ET
    Clin Infect Dis; 2006 Feb; 42(3):356-62. PubMed ID: 16392080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for development of hemolytic uremic syndrome during shigellosis.
    Butler T; Islam MR; Azad MA; Jones PK
    J Pediatr; 1987 Jun; 110(6):894-7. PubMed ID: 3295160
    [No Abstract]   [Full Text] [Related]  

  • 3. A pediatric cluster of Shigella dysenteriae serotype 1 diarrhea with hemolytic uremic syndrome in 2 families from France.
    Houdouin V; Doit C; Mariani P; Brahimi N; Loirat C; Bourrillon A; Bingen E
    Clin Infect Dis; 2004 May; 38(9):e96-9. PubMed ID: 15127361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to Shiga toxin in the serum of children with Shigella-associated haemolytic uraemic syndrome.
    Azim T; Rashid A; Qadri F; Sarker MS; Hamadani J; Salam MA; Wahed MA; Albert MJ
    J Med Microbiol; 1999 Jan; 48(1):11-16. PubMed ID: 9920120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemolytic uremic syndrome associated with shigellosis: report of two cases.
    Rongnoparat C; Panpanit R
    Southeast Asian J Trop Med Public Health; 1987 Jun; 18(2):226-8. PubMed ID: 3313740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans.
    Friedrich AW; Zhang W; Bielaszewska M; Mellmann A; Köck R; Fruth A; Tschäpe H; Karch H
    Clin Infect Dis; 2007 Jul; 45(1):39-45. PubMed ID: 17554698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-dysenteric hemolytic uremic syndrome in children during an epidemic of Shigella dysentery in Kwazulu/Natal.
    Bhimma R; Rollins NC; Coovadia HM; Adhikari M
    Pediatr Nephrol; 1997 Oct; 11(5):560-4. PubMed ID: 9323280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escherichia coli O157:H7 infections: discordance between filterable fecal shiga toxin and disease outcome.
    Cornick NA; Jelacic S; Ciol MA; Tarr PI
    J Infect Dis; 2002 Jul; 186(1):57-63. PubMed ID: 12089662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cluster of hemolytic-uremic syndrome caused by Shiga toxin-producing Escherichia coli O26:H11.
    Misselwitz J; Karch H; Bielazewska M; John U; Ringelmann F; Rönnefarth G; Patzer L
    Pediatr Infect Dis J; 2003 Apr; 22(4):349-54. PubMed ID: 12690276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemolytic uraemic syndrome due to ciprofloxacin-resistant Shigella dysenteriae serotype 1.
    Taneja N; Lyngdoh VW; Sharma M
    J Med Microbiol; 2005 Oct; 54(Pt 10):997-998. PubMed ID: 16157557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemolytic uraemic syndrome during shigellosis.
    Butler T
    Trans R Soc Trop Med Hyg; 2012 Jul; 106(7):395-9. PubMed ID: 22579556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental In Vivo Models of Bacterial Shiga Toxin-Associated Hemolytic Uremic Syndrome.
    Jeong YJ; Park SK; Yoon SJ; Park YJ; Lee MS
    J Microbiol Biotechnol; 2018 Sep; 28(9):1413-1425. PubMed ID: 29926707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Shiga toxin-producing Shigella species isolated from French travellers returning from the Caribbean: an emerging pathogen with international implications.
    Gray MD; Lacher DW; Leonard SR; Abbott J; Zhao S; Lampel KA; Prothery E; Gouali M; Weill FX; Maurelli AT
    Clin Microbiol Infect; 2015 Aug; 21(8):765.e9-765.e14. PubMed ID: 25980352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shigella dysenteriae type 1 in tourists to Cancun, Mexico.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1988 Aug; 37(31):465. PubMed ID: 3135475
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemolytic uremic syndrome in children of Mendoza, Argentina: association with Shiga toxin-producing Escherichia coli infection].
    Rivas M; Balbi L; Miliwebsky ES; García B; Tous MI; Leardini NA; Prieto MA; Chillemi GM; de Principi ME
    Medicina (B Aires); 1998; 58(1):1-7. PubMed ID: 9674201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemic shigella dysentery in children in northern KwaZulu-Natal.
    Chopra M; Wilkinson D; Stirling S
    S Afr Med J; 1997 Jan; 87(1):48-51. PubMed ID: 9063314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple drug-resistant Shigella dysenteriae type 1 in Rajbari district, Bangladesh.
    Jahan Y; Hossain A
    J Diarrhoeal Dis Res; 1997 Mar; 15(1):17-20. PubMed ID: 9308296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemolytic-uraemic syndrome as a sequela of diarrhoeal disease.
    Walker CL; Applegate JA; Black RE
    J Health Popul Nutr; 2012 Sep; 30(3):257-61. PubMed ID: 23082627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leads from the MMWR. Shigella dysenteriae type 1 in tourists to Cancun, Mexico.
    JAMA; 1988 Sep; 260(10):1349. PubMed ID: 3043025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.